Streptococcus pneumoniae  Serotype Epidemiology among PCV-10 Vaccinated and Unvaccinated Children at Gertrude's Children's Hospital, Nairobi County: A Cross-Sectional Study

F1000Research
Michael WalekhwaBeatrice Kabera

Abstract

Background: Serotype replacement and emergence of multidrug resistant S. pneumoniae has exacerbated the need for continuous regional serotype surveillance especially in the developing world. We investigated S. pneumoniae serotypes circulating among vaccinated and unvaccinated children ≤5 years in Nairobi County post PCV10 era. Methods: A total of 206 vaccinated and unvaccinated children attending Gertrude's Children's Hospital (GCH) were recruited for this study. Nasopharyngeal swabs collected using Copan Flocked Swabs were the main study specimen. Culturing and isolation of S. pneumoniae was done on BA with gentamicin and BA plates respectively at the GCH main laboratory. Serotyping was done using the Quellung reaction at the KEMRI-Wellcome Trust, Kilifi.  Results: Out of the 206 subjects sampled, 20.39% (42) were found to be carriers of S. pneumoniae. About 52% (n=22) of the S. pneumoniae carriers had received the recommended dose of PCV-10, while 48% (n=20) of the carriers had not. Almost all (n=41; 19.90% of subjects) isolates contained non-vaccine type S. pneumoniae serotypes, while n=1 of the serotypes (in 0.49% of subjects) were untypeable. Serotypes 28F, 6A, 11A, 3 and 7C were prevalent in both vaccinated and unvaccinat...Continue Reading

References

Aug 30, 2001·Journal of Clinical Microbiology·J A KelloggM C Smith
Feb 19, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Philip C HillRichard A Adegbola
Sep 15, 2009·Lancet·Katherine L O'BrienUNKNOWN Hib and Pneumococcal Global Burden of Disease Study Team
Feb 6, 2010·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·A M Mitchell, T J Mitchell
Jun 19, 2010·International Journal of Antimicrobial Agents·Ronald N JonesHelio S Sader
Apr 26, 2011·Current Opinion in Immunology·Kristin L Moffitt, Richard Malley
Jul 27, 2011·Antimicrobial Agents and Chemotherapy·Matthieu Domenech de CellèsDidier Guillemot
Jan 24, 2012·Vaccine·Carlos Castañeda-OrjuelaFernando De la Hoz-Restrepo
Feb 15, 2012·Vaccine·Jae-Hoon SongBernard Fritzell
Feb 11, 2014·Trends in Microbiology·Calum JohnstonJean-Pierre Claverys
Jun 27, 2014·The Journal of Infection·Charles Feldman, Ronald Anderson
Sep 5, 2015·Science·William Colglazier

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Cavernous Hemangioma

Cavernous hemangioma is a blood vessel defect or benign tumor that leads to leakage of blood to the surrounding tissues. This can occur in several organs including the brain, which can lead to seizures. Discover the latest research on cavernous hemangiomas here.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antibodies: Agglutination

Antibody-mediated agglutination is the clumping of cells in the presence of antibody, which binds multiple cells together. This enhances the clearance of pathogens. Find the latest research on antibody-mediated agglutination here.